UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Scientific reports, 2022-05, Vol.12 (1), p.7140-10, Article 7140

2022

Volltextzugriff (PDF)

TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System

Scientific reports, 2022-11, Vol.12 (1), p.19569-19569, Article 19569

2022

Volltextzugriff (PDF)

Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database

Journal of investigative dermatology, 2024-03, Vol.144 (3), p.708-710.e7

2024

Volltextzugriff (PDF)

Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2023-05, Vol.37 (3), p.397-407

2023

Volltextzugriff (PDF)

Use of progestogens and the risk of intracranial meningioma: national case-control study

BMJ (Online), 2024-03, Vol.384, p.e078078

2024

Volltextzugriff (PDF)

Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System

Rheumatic & musculoskeletal diseases open, 2024-03, Vol.10 (1), p.e003531

2024

Volltextzugriff (PDF)

Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study

European journal of neurology, 2022-09, Vol.29 (9), p.2801-2809

2022

Volltextzugriff (PDF)

Do older adults know the purpose of their medications? A survey among community-dwelling people

European journal of clinical pharmacology, 2019-02, Vol.75 (2), p.255-263

2019

Volltextzugriff (PDF)

Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002681

2022

Volltextzugriff (PDF)

Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy

Transplant international, 2022-04, Vol.35, p.10228-10228

2022

Volltextzugriff (PDF)

Use of progestogens and the risk of intracranial meningioma: national case-control study

BMJ (Online), 2024-03, p.q776

2024

Volltextzugriff (PDF)

Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study

The Lancet regional health. Europe, 2024-07, Vol.42, p.100928-100928, Article 100928

2024

Volltextzugriff (PDF)

Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort studyResearch in context

The Lancet regional health. Europe, 2024-07, Vol.42, p.100928

2024

Volltextzugriff (PDF)

Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study

Annals of the rheumatic diseases, 2023-02, Vol.82 (2), p.182-188

2023

Volltextzugriff (PDF)

Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study

Arthritis & rheumatology (Hoboken, N.J.), 2024-09, Vol.76 (9), p.1364-1376

2024

Volltextzugriff (PDF)

Les quatre saisons de la dermatologie : saisonnalité des dermatoses aux urgences dermatologiques

Annales de Dermatologie et de Vénéréologie - FMC, 2021-12, Vol.1 (8), p.A299-A300

2021

Volltextzugriff (PDF)

Les évènements indésirables associés aux inhibiteurs de Janus kinases : 126 815 rapports de pharmacovigilance

Annales de Dermatologie et de Vénéréologie - FMC, 2021-12, Vol.1 (8), p.A97-A98

2021

Volltextzugriff (PDF)

32696 Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB137-AB137

2022

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(18)

Sprache

Englisch
(16)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System

Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database

Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System

Use of progestogens and the risk of intracranial meningioma: national case-control study

Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System

Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study

Do older adults know the purpose of their medications? A survey among community-dwelling people

Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)

Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy

Use of progestogens and the risk of intracranial meningioma: national case-control study

Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study

Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort studyResearch in context

Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study

Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study

Les quatre saisons de la dermatologie : saisonnalité des dermatoses aux urgences dermatologiques

Les évènements indésirables associés aux inhibiteurs de Janus kinases : 126 815 rapports de pharmacovigilance

32696 Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Suchergebnisse filtern